Blueprint Medicines Operating Expenses 2014-2024 | BPMC

Blueprint Medicines operating expenses for the twelve months ending September 30, 2024 were $0.710B, a 4.93% decline year-over-year.

  • Blueprint Medicines annual operating expenses for 2023 were $0.736B, a 0.8% decline from 2022.
  • Blueprint Medicines annual operating expenses for 2022 were $0.742B, a 9.79% decline from 2021.
  • Blueprint Medicines annual operating expenses for 2021 were $0.822B, a 69.49% increase from 2020.

Blueprint Medicines Operating Expenses 2014-2024 | BPMC

  • Blueprint Medicines annual operating expenses for 2023 were $0.736B, a 0.8% decline from 2022.
  • Blueprint Medicines annual operating expenses for 2022 were $0.742B, a 9.79% decline from 2021.
  • Blueprint Medicines annual operating expenses for 2021 were $0.822B, a 69.49% increase from 2020.